UNSPSC 51372700: Controlled substance analgesic azepines

Controlled substance analgesic drugs made from seven membered heterocyclic rings containing a nitrogen atom.

UNSPSC 51372700 Controlled substance analgesic azepines is a Class code covering the procurement of pharmaceutical products and related medical supplies by state and local health agencies, departments, and special-purpose purchasing cooperatives. State and local governments are buying naloxone, opioid antagonists, generic multi-source pharmaceuticals, over-the-counter products, and drug deactivation systems through this code to support community health initiatives, emergency response programs, and pharmacy benefit management. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across multiple member jurisdictions and authorized pharmaceutical wholesalers.

Recent opportunities span Florida, Texas, and the Minnesota-led MMCAP cooperative serving multiple states including Oregon. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Direct-to-Manufacturer Prescriptions program allowing state pharmacy benefit plans to contract directly with pharmaceutical manufacturers outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products to be awarded by May 15, 2026, and effective July 1, 2026, with pricing weighted at 75 percent and evaluations including cGMP compliance, Drug Supply Chain Security Act certification, and EDI capability.